A new trading day began on Friday, with Palisade Bio Inc (NASDAQ: PALI) stock price up 6.70% from the previous day of trading, before settling in for the closing price of $1.94. PALI’s price has ranged from $0.53 to $3.30 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 77.35% over the last five years. Meanwhile, its annual earnings per share averaged 85.28%. With a float of $132.98 million, this company’s outstanding shares have now reached $133.00 million.
The firm has a total of 8 workers. Let’s measure their productivity.
Palisade Bio Inc (PALI) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Palisade Bio Inc is 0.02%, while institutional ownership is 43.67%.
Palisade Bio Inc (PALI) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -2.32 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 85.28% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 51.67% during the next five years compared to 77.35% growth over the previous five years of trading.
Palisade Bio Inc (NASDAQ: PALI) Trading Performance Indicators
Here are Palisade Bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.16, a number that is poised to hit -0.27 in the next quarter and is forecasted to reach -0.76 in one year’s time.
Technical Analysis of Palisade Bio Inc (PALI)
Analysing the last 5-days average volume posted by the [Palisade Bio Inc, PALI], we can find that recorded value of 6.49 million was better than the volume posted last year of 2.93 million. As of the previous 9 days, the stock’s Stochastic %D was 83.33%.
During the past 100 days, Palisade Bio Inc’s (PALI) raw stochastic average was set at 88.00%, which indicates a significant increase from 87.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.19 in the past 14 days, which was higher than the 0.13 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.19, while its 200-day Moving Average is $0.95. Now, the first resistance to watch is $2.13. This is followed by the second major resistance level at $2.20. The third major resistance level sits at $2.30. If the price goes on to break the first support level at $1.96, it is likely to go to the next support level at $1.86. Should the price break the second support level, the third support level stands at $1.79.
Palisade Bio Inc (NASDAQ: PALI) Key Stats
With a market capitalization of 275.32 million, the company has a total of 9,119K Shares Outstanding. Currently, annual sales are 0 K while annual income is -14,440 K. The company’s previous quarter sales were 0 K while its latest quarter income was -2,780 K.
